Sentences with phrase «strategies for disease»

Naturopathic medicine can be used in many ways — to treat acute and chronic health conditions, to complement conventional medical care, and to create strategies for disease prevention and health creation.

Dr. Akassoglou has also developed imaging techniques to study neurovascular diseases in vivo, which will enable a better understanding of the origins and progress of these diseases and thus find more practical strategies for disease detection and treatment.

In HDNetDB we have developed a computational tool which allows those scientists free and open access, helping them to identify new molecular targets for the development of new drug strategies for the disease.

In particular, the comparison of gene sequences in large numbers of patients and controls will be a key step in strategies for disease gene identification.

The researchers say that identifying these high use farms will enable targeted strategies for disease prevention, to help reduce antibiotic use in dairy herds and combat antibiotic resistance in the farming industry.

Arman first worked to gain a thorough understanding of the medical conditions Eos was hoping to target, and then to identify the standard treatment strategies for those diseases.

Thus, mitochondrial rescue agents may be a promising novel strategy for disease - modifying therapy in LRRK2 - related Parkinson's.»

«This finding opens a new avenue for a therapeutic strategy for this disease,» said Andrew Berglund, Ph.D., a professor of biochemistry and molecular biology in the University of Florida College of Medicine.

If BIN1 is found to be involved in disease pathogenesis, it will advance efforts towards targeting BIN1 as a potential strategy for disease modification.

Should collaborations like these prove to be important also in human breast cancer, disrupting key interactions may be a novel treatment strategy for the disease.

Prevention is the organic farmer's primary strategy for disease, weed, and insect control.

We don't know for sure, but it is an option for those who are interested in employing a novel dietary strategy for disease risk reduction.

Until well - designed studies are completed and thousands of pet owners make a concerted effort to help with potential retrospective studies, nosodes remain an unknown quantity, and I do not recommend using them as a sole strategy for disease prevention.»

Until well designed studies are completed and thousands of pet owners make a concerted effort to help with potential retrospective studies, nosodes remain an unknown quantity, and I do not recommend using them as a sole strategy for disease prevention.

Not exact matches

Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.

The PGS platform promised genetic risk reports for more than 250 disease at the time — but, after the FDA smackdown, 23andMe was forced to stop marketing the service and pursue a piecemeal strategy of winning regulatory approval of individual tests.

For a century and a half, epidemiology has been an effective strategy for tracing the root causes of infectious disease outbreaks — as John Snow demonstrated in 1854, when he painstakingly mapped cases of cholera in London and eventually traced them to a single contaminated well and water pump in the Soho district of the ciFor a century and a half, epidemiology has been an effective strategy for tracing the root causes of infectious disease outbreaks — as John Snow demonstrated in 1854, when he painstakingly mapped cases of cholera in London and eventually traced them to a single contaminated well and water pump in the Soho district of the cifor tracing the root causes of infectious disease outbreaks — as John Snow demonstrated in 1854, when he painstakingly mapped cases of cholera in London and eventually traced them to a single contaminated well and water pump in the Soho district of the city.

In an interview with Medium Andrew Conrad, head of life sciences at Google X, explained why our current strategy for treating serious diseases, particularly cancer, is fundamentally backwards:

Google's pill aims to change the strategy from reactive to proactive — adopting a «preventative maintenance» approach — by continuously monitoring the body for disease triggers, so they can be identified and treated as soon as they appear.

In those areas that we have mapped, it typically takes us a few hours to go from a mechanism - inspired idea for treating a disease to knowing the companies that might have relevant clinical and preclinical assets to license, the companies from whom a candidate could be commissioned, trial designs and endpoints, competing and complementary agents, current and future standard of care, market size, comparable pricing, financing strategy, and potential acquirers, all meant to enable a thoughtful first - pass assessment of whether an idea could be worth a much deeper assessment.

Intermittent Fasting is proving to be a simple and effective strategy for avoiding major dietary changes while achieving strong effects not just for one disease risk factor, but for an array of factors that constitutes the foundation for metabolic syndrome, cardiovascular disease, cancer, and possibly neurodegenerative diseases.

In the eight years since, Shepard's quest to develop gluten - free strategies and products, particularly ones that satisfy her yen for baking, has paralleled the increase in known cases of the disease and in the market for products related to it.

Dietary strategies for managing weight and other risk factors of obesity - related chronic diseases such as type 2 diabetes, cardiovascular disease and depression.

The focus of her study is improving the nutrition strategies for transition cows that are more susceptible to disease and metabolic disorders such as ketosis.

Strategies to Prevent Obesity in the United States from the US Centers for Disease Control and Prevention.

Moreover, in 2002, the Government produced an Organic Action Plan as part of its Strategy for Sustainable Farming and Food, drawn up in response to the 2001 Foot and Mouth Disease epidemic.

Monday Questions - Communities and Local Government Motion - Consideration of an allocation of time motion Business - Sunday Trading (London Olympic Games and Paralympic Games) Bill Adjournment debate - Developing a UK strategy for rare diseases - Mr Edward Timpson

Saraki, a trained medical doctor, stated that in order to reduce the burden on the nation's healthcare system, Nigeria must begin to push for preventive strategies to curb the spread of diseases and to stop citizens from falling sick.

«In order to reduce the burden on our healthcare system, Nigeria must begin to push for preventive strategies to curb the spread of diseases, any healthcare reform in Nigeria must start with an emphasis on prevention, rather than cure,» he said.

«We could apply the strategy used in this study to quickly identify and design small molecule drugs for other RNA - associated diseases,» explained study first author Sai Velagapudi, a research associate in the Disney lab.

Still, it seems that the cocoon strategy pales in comparison to the protection offered by vaccination during pregnancy, an approach that the Centers for Disease Control and Prevention recommends.

However these new discoveries provide us with vital information to develop new treatment strategies that could lead to a safe and effective way of switching off inflammation for treating disease,» Dr Nachbur said.

McCallion's strategy to make sense of all this data looks at the active genes in cells affected by a disease, groups of genes that interact with one another, their vulnerability to mutation and information from past scientific studies to filter more than a thousand gene candidates for disease risk down to just a handful within any one implicated region.

Knowing the key players in the entire NOD2 pathway, from initiators to enhancers, would pave the way for new strategies to treat inflammatory diseases, Mr Stafford said.

Over the past 29 years, TDR has supported scientists both in developed countries DECs to produce new tools and strategies for controlling tropical diseases.

These observations suggest that blocking beta - arrestin - 1 may be an effective therapeutic strategy for metastatic disease.

The review calls for improved global surveillance strategies to combat the emergence of infectious diseases such as the recent outbreak of Ebola in West Africa that has claimed the lives of 122 people in the countries of Guinea and Liberia.

From a clinical standpoint, the findings suggest that screening for rs9349379 could improve risk assessment for vascular diseases, as well as strategies for prevention and treatment.

«While this strategy is very promising for a disease with few therapeutic options, it's crucially important to keep in mind that these tumors are located in precarious neuroanatomical sites that just do not tolerate much swelling — and those regions are already expanded by tumors,» Monje said.

«Steep funding cuts for the federal health agencies are counterproductive at a time when innovative research is moving us closer to identifying solutions for rare diseases, new prevention strategies to protect Americans from deadly and costly conditions, advances in gene therapy, new technologies for understanding the brain, and treatments that harness the ability of our immune system to fight cancer.»

According to researchers, their future research will analyze the cost - effectiveness of a new strategy of incorporating these non-invasive imaging tools into future prevention and diagnostic protocols for cardiovascular disease and to better define their use.

A new strategy — an injectable antibody — for lowering blood lipids and thereby potentially preventing coronary artery disease and other conditions caused by the build - up of fats, cholesterol, and other substances on the artery walls, is supported by findings from two new studies from researchers in the Perelman School of Medicine at the University of Pennsylvania.

Cardiac function assessment for heart failure, coronary angiography for ischaemic heart disease and Holter ECG monitoring for lethal arrhythmias can identify the type of myocardial injury and help physicians select a prophylactic therapeutic strategy against sudden cardiac death in hemodialysis patients.»

Institute research efforts include the search for new ways of fighting disease and hunger, examining leading questions in mathematics and computer science, probing the physics of matter and the universe, creating novel materials and developing new strategies for protecting the environment.

Effective strategies for preventing this disease are lacking.

The final results from an international clinical trial involving nearly 2,000 patients with Crohn's disease support the use of a new management strategy referred to as accelerated step - care as a best practice for the care of active Crohn's disease.

The next objective of the researchers is to decode the action mechanism of TREX2 in the development and maintenance of psoriasis, so as to design new therapeutic strategies for the treatment of this disease.

Because there are no vaccines or cures for these viruses there is an increased urgency of those in the public health sector to identify alternative strategies to manage the disease, of which an early warning system is included.

Therefore, the blockage of this pathway is one of the most commonly suggested strategies for the treatment of this disease.

«We have identified a pathway in microglia that may be targeted to ultimately slow disease progression in ALS and are exploring potential therapeutic strategies and may have broader implications for diseases such as Alzheimer's and Parkinson's Disease amongst others.disease progression in ALS and are exploring potential therapeutic strategies and may have broader implications for diseases such as Alzheimer's and Parkinson's Disease amongst others.Disease amongst others.»